Belvedere Trading LLC Moon Lake Immunotherapeutics Call Options Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Nov 01, 2024
BUY
$38.43 - $48.6 $49,959 - $63,180
1,300 New
1,300 $57,000
Q2 2024

Aug 09, 2024
SELL
$38.43 - $48.6 $34,587 - $43,740
-900 Reduced 40.91%
1,300 $57,000
Q1 2024

May 09, 2024
BUY
$43.78 - $63.86 $17,512 - $25,544
400 Added 22.22%
2,200 $110,000
Q4 2023

Feb 13, 2024
SELL
$36.35 - $63.02 $14,540 - $25,208
-400 Reduced 18.18%
1,800 $108,000
Q3 2023

Oct 27, 2023
BUY
$48.35 - $61.26 $106,370 - $134,772
2,200 New
2,200 $125,000

Others Institutions Holding MLTX

# of Institutions
124
Shares Held
58.2M
Call Options Held
52.2K
Put Options Held
38K
View Full List

About MoonLake Immunotherapeutics

MLTX Quotes by TradingView
  • Ticker MLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,925,600
  • Market Cap $1.8B
  • Description
  • MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...
More about MLTX
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email